0001214659-18-006012.txt : 20180912 0001214659-18-006012.hdr.sgml : 20180912 20180912151951 ACCESSION NUMBER: 0001214659-18-006012 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180911 FILED AS OF DATE: 20180912 DATE AS OF CHANGE: 20180912 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McManigle Mark Drew CENTRAL INDEX KEY: 0001751524 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34637 FILM NUMBER: 181066740 MAIL ADDRESS: STREET 1: PENNZOIL PLACE 700 MILAM, SUITE 1300 CITY: HOUSTON STATE: TX ZIP: 77002 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Anthera Pharmaceuticals Inc CENTRAL INDEX KEY: 0001316175 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 201852016 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 25801 INDUSTRIAL BOULEVARD, SUITE B CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: (510) 856-5600 MAIL ADDRESS: STREET 1: 25801 INDUSTRIAL BOULEVARD, SUITE B CITY: HAYWARD STATE: CA ZIP: 94545 3 1 marketforms-42916.xml PRIMARY DOCUMENT X0206 3 2018-09-11 1 0001316175 Anthera Pharmaceuticals Inc ANTH 0001751524 McManigle Mark Drew 700 MILAM, SUITE 1300 PENZOIL BUILDING, NORTH TOWER HOUSTON TX 77003 true true false false Chief Liquidating Officer /s/ Drew McManigle 2018-09-11